Bar'ernye metody kontratseptsii kak profilaktika razvitiya infektsiy, peredayushchikhsya polovym putem, i patologii sheyki matki

Por E A Mezhevitinova
Publicado em 2001-08-01

Transdermal estrogen in women of reproductive age (for the practitioner's aid)

Por E A Mezhevitinova
Publicado em 2016-04-01

PRECANCEROUS CERVICAL LESIONS

Por E. A. Mezhevitinova, P. R. Abakarova, Y. S. Khlebkova
Publicado em 2016-12-01

Non-surgical treatment of uterine fibroids. Efficacy of the selective progesterone receptor modulator

Por E. R. Dovletkhanova, E. A. Mezhevitinova, V. N. Prilepskaya
Publicado em 2019-04-01

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis

Por E. A. Mezhevitinova, P. R. Abakarova, Sh. M. Pogosyan
Publicado em 2018-09-01

Medical eligibility criteria for using various methods of contraception

Por V N Prilepskaya, E A Mezhevitinova, E L Sheshko
Publicado em 2014-02-01

Dysmenorrhea: effectiveness and acceptability of treatment with a drug containing 2 mg of chloromadinone acetate and 0.03 mg of ethinyl estradiol

Por V N Prilepskaia, A N Mgerian, E A Mezhevitinova
Publicado em 2017-06-01

The use of combined hormonal contraception in the context of the COVID-19 pandemic

Por A. T. Uruymagova, V. N. Prilepskaya, E. A. Mezhevitinova, M. T. Poghosyan
Publicado em 2021-10-01

Vulvovaginitis. Treatment with the use of complex preparations for topical application

Por V N Prilepskaya, E A Mezhevitinova, Yu S Khlebkova, E N Zarubina
Publicado em 2015-12-01

Emergency contraception methods: efficacy, safety and acceptability

Por P. R. Abakarova, K. I. Gusakov, E. R. Dovletkhanova, E. A. Mezhevitinova
Publicado em 2021-10-01

ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA

Por E. R. Dovlethanova, E. A. Mezhevitinova, A. N. Mgeryan, P. R. Abakarova
Publicado em 2017-12-01

NEW MODE OF PROLONGED HORMONAL CONTRACEPTION

Por A. N. Mheryan, P. R. Abakarova, E. R. Dovlethanova, E. A. Mezhevitinova
Publicado em 2017-10-01

PROSPECTS FOR THE USE OF MEDICATIONS CONTAINING DICLOFENAC AND B VITAMINS IN THE TREATMENT OF PRIMARY DYSMENORRHEA

Por E. A. Mezhevitinova, A. N. Mgeryan, P. R. Abakarova, E. R. Dovlethanova
Publicado em 2017-12-01

ACTIVATED GLYCYRRHIZIC ACID IN COMPLEX THERAPY OF RECURRENT GENITAL HERPES

Por P. R. Abakarova, E. A. Mezhevitinova, A. N. Mgeryan, E. R. Davletkhanova
Publicado em 2017-10-01

Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency

Por V N Prilepskaya, E A Mezhevitinova, P R Abakarova, T V Brovkina, Sh M Pogosyan
Publicado em 2013-08-01

Comprehensive assessment of efficacy, tolerability and safety of a third-generation combined hormonal contraceptive

Por E. A. Mezhevitinova, V. A. Burlev, K. R. Nabiyeva, N. A. Ilyasova, E. A. Inozemtseva
Publicado em 2015-12-01

ROLE OF GENOTYPING FEATURES IN THE DEVELOPMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS AND THERAPY TACTICS

Por S. M. Pogosyan, E. A. Mezhevitinova, A. E. Donnikov, V. V. Muravyova, P. R. Abakarova, Y. S. Khlebkova
Publicado em 2017-10-01